BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 21669929)

  • 1. The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications.
    Viveros MP; Llorente R; Suarez J; Llorente-Berzal A; López-Gallardo M; de Fonseca FR
    J Psychopharmacol; 2012 Jan; 26(1):164-76. PubMed ID: 21669929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Framework for sex differences in adolescent neurobiology: a focus on cannabinoids.
    Viveros MP; Marco EM; López-Gallardo M; Garcia-Segura LM; Wagner EJ
    Neurosci Biobehav Rev; 2011 Aug; 35(8):1740-51. PubMed ID: 20869396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cannabis and neurodevelopment: implications for psychiatric disorders.
    Sundram S
    Hum Psychopharmacol; 2006 Jun; 21(4):245-54. PubMed ID: 16783814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
    Schneider M
    Addict Biol; 2008 Jun; 13(2):253-63. PubMed ID: 18482434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cannabinoid-hormone interactions in the regulation of motivational processes.
    López HH
    Horm Behav; 2010 Jun; 58(1):100-10. PubMed ID: 19819241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain.
    Marco EM; Echeverry-Alzate V; López-Moreno JA; Giné E; Peñasco S; Viveros MP
    Behav Pharmacol; 2014 Sep; 25(5-6):547-56. PubMed ID: 25083571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Schizophrenia.
    Leweke FM
    Curr Top Behav Neurosci; 2009; 1():387-96. PubMed ID: 21104393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From endocannabinoid profiling to 'endocannabinoid therapeutics'.
    Ligresti A; Petrosino S; Di Marzo V
    Curr Opin Chem Biol; 2009 Jun; 13(3):321-31. PubMed ID: 19497779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detrimental psychophysiological effects of early maternal deprivation in adolescent and adult rodents: altered responses to cannabinoid exposure.
    Marco EM; Adriani W; Llorente R; Laviola G; Viveros MP
    Neurosci Biobehav Rev; 2009 Apr; 33(4):498-507. PubMed ID: 18457877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The endocannabinoid-CB(1) receptor system in pre- and postnatal life.
    Fride E
    Eur J Pharmacol; 2004 Oct; 500(1-3):289-97. PubMed ID: 15464041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
    Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
    Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activation of cannabinoid receptors during early postnatal development reduces the expression of cell adhesion molecule L1 in the rat brain.
    Gómez M; Hernández M; Fernández-Ruiz J
    Brain Res; 2007 May; 1145():48-55. PubMed ID: 17320842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple roles for the endocannabinoid system during the earliest stages of life: pre- and postnatal development.
    Fride E
    J Neuroendocrinol; 2008 May; 20 Suppl 1():75-81. PubMed ID: 18426504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cannabis and psychiatric disorders: it is not only addiction.
    Leweke FM; Koethe D
    Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy.
    Rice AS; Farquhar-Smith WP; Nagy I
    Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):243-56. PubMed ID: 12052040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Central and peripheral interactions between endocannabinoids and steroids, and implications for drug dependence.
    Maccarrone M
    Life Sci; 2005 Aug; 77(14):1559-68. PubMed ID: 15953622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The endocannabinoid system during development: emphasis on perinatal events and delayed effects.
    Fride E; Gobshtis N; Dahan H; Weller A; Giuffrida A; Ben-Shabat S
    Vitam Horm; 2009; 81():139-58. PubMed ID: 19647111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The neurobiology and evolution of cannabinoid signalling.
    Elphick MR; Egertová M
    Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.
    Bossong MG; Niesink RJ
    Prog Neurobiol; 2010 Nov; 92(3):370-85. PubMed ID: 20624444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid system and psychiatric disorders.
    Parolaro D; Realini N; Vigano D; Guidali C; Rubino T
    Exp Neurol; 2010 Jul; 224(1):3-14. PubMed ID: 20353783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.